In CRC tissues and cells (HCT-116 and HT-29), the expression levels of STS, HSD17B7, and HSD17B12 were found to be elevated, while the expression of HSD17B2 was significantly reduced. This evidence concerns the gene HSD17B12 and colorectal carcinoma.